Why Do Patients with Low-Grade Soft Tissue Sarcoma Die?
- 1 October 2008
- journal article
- clinical trial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (12) , 3550-3560
- https://doi.org/10.1245/s10434-008-0163-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The evolving classification of soft tissue tumours: an update based on the new WHO classificationHistopathology, 2005
- Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise worldHistopathology, 2005
- Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three‐grade systemCancer, 2005
- Interferon-γ and Cancer ImmunoeditingImmunologic Research, 2005
- Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapyCancer, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Prognostic Factors Predictive of Survival and Local Recurrence for Extremity Soft Tissue SarcomaAnnals of Surgery, 1994
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading systemInternational Journal of Cancer, 1984